T Jake Liang

Chief

National Institutes of Health

United States

Research Interests

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

T Jake Liang is the Chief at the National Institutes of Health in the United States. His research focuses on hepatitis viruses, including vaccine development, therapeutic strategies, and the interactions between viral pathogens and host proteins. Recent publications highlight advancements in understanding hepatitis C and B viruses, alongside the application of gene editing technologies in biomedical research.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Collaborators (1)

Jens Bukh

Københavns Universitet

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

T Jake Liang

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Targets of protective immunity and opportunities in hepatitis C virus vaccine development

How a medical mystery led to a cure for viral hepatitis

The Post-Transcriptional Regulatory Element of Hepatitis B Virus: From Discovery to Therapy

Challenge Inoculum for Hepatitis C Virus Controlled Human Infection Model

Development of a highly potent anti-HBs monoclonal antibody for HBV and HDV therapy: An improvement with unsettled questions

Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Is It Time to Be Real?

Hepatitis Delta Virus–Host Protein Interactions: From Entry to Egress

A dual conditional CRISPR-Cas9 system to activate gene editing and reduce off-target effects in human stem cells

Genetically edited hepatic cells expressing the NTCP-S267F variant are resistant to hepatitis B virus infection

Modeling PNPLA3‐Associated NAFLD Using Human‐Induced Pluripotent Stem Cells

Collaborators (1)

Jens Bukh

Make your next move.